Ascentage Pharma Group International (HK:6855) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Ascentage Pharma Group International has announced a significant private placement agreement with Takeda International after market hours on June 14, 2024, involving the issue and allotment of 24,307,322 new shares at a total value of approximately US$75 million. The deal, which will be executed under the company’s General Mandate without additional shareholder approval, represents a premium ranging from 4.55% to 25.12% over recent closing prices. The successful completion of this transaction is still subject to certain conditions, and J.P. Morgan and Citi are acting as Structuring Agents.
For further insights into HK:6855 stock, check out TipRanks’ Stock Analysis page.